WE-LaunchListed company MEI Pharma completes $100 million private placement, to be used for Litecoin strategic reserves
Odaily News MEI Pharma announced the completion of a $100 million private placement financing, selling 29,239,767 shares of common stock or prepaid warrants of equivalent value at $3.42 per share. The proceeds will be used to establish a strategic reserve of Litecoin.
The company also appointed Charlie Lee, the founder of Litecoin and the lead investor in this private placement, to join the board of directors, and designated GSR as its digital asset and fund management consultant to oversee the execution of Litecoin reserve strategy. (Businesswire)
You may also like
WEEX 2025 Global Offline Events Hub
From the vibrant streets of Hong Kong to the sunlit shores of Lisbon, 2025 marks a defining year for WEEX on the global stage.
WEEX Steals the Show at BlockchainRIO 2025: First LATAM Appearance Unlocks Brazil’s Crypto Potential
In 2025, WEEX lit up Latin America with its debut at BlockchainRIO as Platinum Sponsor. With bold vision and unstoppable momentum, the rising exchange made waves across the region’s crypto scene.
Litecoin (LTC) Coin Price Prediction & Forecasts: Will It Surge to $150 by June 2025 with a 30% Rally?
Introduction to Litecoin (LTC) Coin Price Prediction Let me share a quick story with you. A few years…
WEEX Global Journey 2025: Connecting the World of Web3
WEEX’s H2 2025 global tour is hitting top blockchain stages and exclusive community meetups worldwide — connecting with real builders, sparking honest conversations, and creating lasting trust. Our mission: make trading simpler, confidence stronger, and crypto trusted across the globe.
Crypto ETPs Surge with $2.1B Inflows as Ether Dominates Gains on August 7, 2025
Imagine the crypto market as a thrilling rollercoaster ride – full of ups and downs, but lately, it’s…
Gainers
Customer Support：@weikecs
Business Cooperation：@weikecs
Quant Trading & MM：[email protected]
VIP Services：[email protected]
App